MW, B., JB, V., JE, R., AM, F., A, N., A, D., . . . A, B. (2025). Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America. Journal of cardiac failure, 31(2), 456. https://doi.org/10.1016/j.cardfail.2024.08.046
Chicago Style (17th ed.) CitationMW, Bloom, et al. "Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: A Supplement to the Scientific Statement from the Heart Failure Society of America." Journal of Cardiac Failure 31, no. 2 (2025): 456. https://doi.org/10.1016/j.cardfail.2024.08.046.
MLA (9th ed.) CitationMW, Bloom, et al. "Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: A Supplement to the Scientific Statement from the Heart Failure Society of America." Journal of Cardiac Failure, vol. 31, no. 2, 2025, p. 456, https://doi.org/10.1016/j.cardfail.2024.08.046.